ATT Stock Analysis: Attendo (publ) | ST
Medical Care Facilities | ST, Sweden | Market Cap: 17.047m SEK | 12M Return: 73.4% | SE0007666110 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 29.6M
EPS Trend: 98.0%
Qual. Beats: 4
Rev. Trend: 83.1%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 10.8 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Attendo AB (publ) is a Sweden-based provider of health and care services operating across Scandinavia and Finland. Founded in 1985 and headquartered in Danderyd, the company delivers a wide range of care solutions, including nursing homes for individuals with dementia or somatic needs, home care services such as personal care, meals, cleaning, laundry, and home health care, as well as day care, respite care, and short-term accommodation. It also offers specialized residential care for people with neuropsychiatric and psychosocial disorders, family and crisis homes, dependency care, schools, and various forms of supportive housing for individuals with disabilities across different age groups.
As a Health Care Facilities operator under the GICS classification, Attendo primarily serves the Nordic care market, where public authorities (often municipalities) are the principal purchasers of elderly and disability care services. The companys business model combines publicly funded care contracts with private-pay offerings, with municipalities acting as the dominant client base for both institutional and home-based services.
- Swedish government care budget increases boost Attendo contract revenues
- Finland private care demand expands amid aging population
- Wage inflation and staff shortages pressure Scandinavian care margins
| Net Income: 976.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 1.14 > 1.0 |
| NWC/Revenue: -5.01% < 20% (prev -7.26%; Δ 2.25% < -1%) |
| CFO/TA 0.12 > 3% & CFO 2.91b > Net Income 976.0m |
| Net Debt (28.7b) to EBITDA (4.05b): 7.09 < 3 |
| Current Ratio: 0.79 > 1.5 & < 3 |
| Outstanding Shares: last quarter (143.9m) vs 12m ago -4.26% < -2% |
| Gross Margin: 10.23% > 18% (prev 34.53%; Δ -24.31% > 0.5%) |
| Asset Turnover: 75.13% > 50% (prev 75.62%; Δ -0.50% > 0%) |
| Interest Coverage Ratio: 2.53 > 6 (EBIT TTM 2.02b / Interest Expense TTM 796.0m) |
| A: -0.04 (Total Current Assets 3.60b - Total Current Liabilities 4.55b) / Total Assets 25.1b |
| B: 0.04 (Retained Earnings 913.0m / Total Assets 25.1b) |
| C: 0.08 (EBIT TTM 2.02b / Avg Total Assets 25.3b) |
| D: 0.27 (Book Value of Equity 5.29b / Total Liabilities 19.9b) |
| Altman-Z'' = 0.69 = B |
| DSRI: 0.98 (Receivables 1.62b/1.67b, Revenue 19.0b/19.2b) |
| GMI: 3.38 (GM 34.53% / 10.23%) |
| AQI: 1.01 (AQ_t 0.36 / AQ_t-1 0.36) |
| SGI: 0.99 (Revenue 19.0b / 19.2b) |
| TATA: -0.08 (NI 976.0m - CFO 2.91b) / TA 25.1b) |
| Beneish M = -0.90 (Cap -4..+1) = D |
As of October 10, 2026, the stock is trading at SEK 120.00 with a total of 224,451 shares traded. Over the past week, the price has changed by -2.04%, over one month by -1.72%, over three months by +10.09% and over the past year by +73.42%.
Current recommended Stop Loss: 116.00 (which is 3.3% or 1.2 ATR below the current price).
Attendo (publ) has no consensus analysts rating.
P/E Trailing = 18.356
P/E Forward = 58.4795
P/S = 0.8985
P/B = 3.4235
P/EG = 1.44
Revenue TTM = 19.0b SEK
EBIT TTM = 2.02b SEK
EBITDA TTM = 4.05b SEK
Long Term Debt = 3.29b SEK (from longTermDebt, last quarter)
Short Term Debt = 1.69b SEK (from shortTermDebt, last quarter)
Debt = 30.1b SEK (from shortLongTermDebtTotal, last quarter) + Leases 13.4b
Net Debt = 28.7b SEK (calculated: Debt 30.1b - CCE 1.39b)
Enterprise Value = 45.7b SEK (17.0b + Debt 30.1b - CCE 1.39b)
Interest Coverage Ratio = 2.53 (Ebit TTM 2.02b / Interest Expense TTM 796.0m)
EV/FCF = 16.80x (Enterprise Value 45.7b / FCF TTM 2.72b)
FCF Yield = 5.95% (FCF TTM 2.72b / Enterprise Value 45.7b)
FCF Margin = 14.35% (FCF TTM 2.72b / Revenue TTM 19.0b)
Net Margin = 5.14% (Net Income TTM 976.0m / Revenue TTM 19.0b)
Gross Margin = 10.23% ((Revenue TTM 19.0b - Cost of Revenue TTM 17.0b) / Revenue TTM)
Gross Margin QoQ = 9.13% (prev 9.37%)
Tobins Q-Ratio = 1.82 (Enterprise Value 45.7b / Total Assets 25.1b)
Interest Expense / Debt = 2.65% (Interest Expense 796.0m / Debt 30.1b)
Taxrate = 20.62% (254.0m / 1.23b)
NOPAT = 1.60b (EBIT 2.02b * (1 - 20.62%))
Current Ratio = 0.79 (Total Current Assets 3.60b / Total Current Liabilities 4.55b)
Debt / Equity = 5.69 (Debt 30.1b / totalStockholderEquity, last quarter 5.29b)
Debt / EBITDA = 7.09 (Net Debt 28.7b / EBITDA 4.05b)
Debt / FCF = 10.54 (Net Debt 28.7b / FCF TTM 2.72b)
Total Stockholder Equity = 5.39b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.86% (Net Income 976.0m / Total Assets 25.1b)
RoE = 18.11% (Net Income TTM 976.0m / Total Stockholder Equity 5.39b)
RoCE = 23.23% (EBIT 2.02b / Capital Employed (Equity 5.39b + L.T.Debt 3.29b))
RoIC = 7.51% (NOPAT 1.60b / Invested Capital 21.3b)
WACC = 3.54% (E(17.0b)/V(47.1b) * Re(6.08%) + D(30.1b)/V(47.1b) * Rd(2.65%) * (1-Tc(0.21)))
Discount Rate = 6.08% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -99.56 | Cagr: -4.82%
[DCF] Terminal Value 76.76% ; FCFF base≈2.62b ; Y1≈2.86b ; Y5≈3.60b
[DCF] Fair Price = 188.2 (EV 55.1b - Net Debt 28.7b = Equity 26.4b / Shares 140.1m; r=8.35% [WACC [floored]]; 5y FCF grow 10.87% → 2.50% )
EPS Correlation: 98.03 | EPS CAGR: 45.32% | SUE: 3.44 | # QB: 4
Revenue Correlation: 83.08 | Revenue CAGR: 4.49% | SUE: 0.01 | # QB: 0
EPS current Quarter (2026-09-30): EPS=2.39 | Chg30d=+0.42% | Revisions=+25% | Analysts=1
EPS current Year (2026-12-31): EPS=7.39 | Chg30d=+2.28% | Revisions=+0% | GrowthEPS=+22.6% | GrowthRev=+0.2%
EPS next Year (2027-12-31): EPS=8.56 | Chg30d=+4.07% | Revisions=+40% | GrowthEPS=+15.8% | GrowthRev=+4.9%
[Analyst] Revisions Ratio: +38% (up=4, down=1)